Newsroom | 5772 results

HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. His promotion reflects NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth. Greg joined NMS Labs in April 2023 as Controller. In this role, he oversaw the organization’s finance and accounting functions, supporting both day-to-day opera...

NEWARK, Del. & WAUWATOSA, Wis.--(BUSINESS WIRE)--N-Zyme Biomedical Closes US$4.6 Million Series A Financing to Advance Clinical Development....

MILWAUKEE--(BUSINESS WIRE)--Estrigenix Therapeutics closed the first tranche of its $2M Series Seed round, led by Talents Fund I, advancing its ERβ platform for women's health....

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026. Canopy Growth CEO Luc Mongeau will be presenting on Tuesday, August 11 at 12:00 p.m. The presentation will be publicly accessible via live webcast at https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/8jLaQ2EHsfTiWktFQKVomw, and archived for 180 days. Canaccord Genuity's...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 30,330 common shares of the Company (the "Options") with effective grant dates of July 20, 2026....

LA FORTUNA, Costa Rica--(BUSINESS WIRE)--As burnout, digital overload and constant distraction become defining challenges of modern life, a new kind of wellness destination has opened in Costa Rica- one designed not to help people escape the world, but to reconnect with it. Set on 118 acres of rainforest beneath the iconic Arenal Volcano, The Vessyl is the world's first 4D Sound Wellness Resort, introducing a new category of immersive hospitality centered on personalized transformation, nervous...

LONDON--(BUSINESS WIRE)--Clinigen, the global pharmaceutical services company, today announced the appointment of Greg Skalicky as Group Chief Executive Officer....

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders, today announced results from a new healthcare claims study of treatment patterns of newly diagnosed and established GAD patients, including pharmacotherapy use, discontinuation, switching and treatment progression. The fi...

LONDON--(BUSINESS WIRE)--Curaleaf International, one of the global leaders in medical cannabis, announces the launch of the Curaleaf Education Platform, providing access to CPD-accredited medical cannabis training for healthcare professionals across the UK. A Curaleaf survey of UK GPs found that just 4% had received any formal education on medical cannabis, and 81% described their understanding of it as limited or non-existent, with 55% saying they would need to better understand medical cannab...